Xuanming Chen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xuanming Chen

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Bioorganic Chemistry|August 14, 2022

SKLB-14b, a novel oral microtubule-destabilizing agent based on hydroxamic acid with potent anti-tumor and anti-multidrug resistance activitiesWanhua Zhang, Linyu Yang, Wenting Si, et al.

Cell Reports|January 18, 2026

Cancer-associated fibroblast-derived extracellular vesicles deliver ATP6V1C1 to promote lung adenocarcinoma metastasis via the ID1-IGFBP3 axisXuanming Chen, Jue Li, Cheng Shen, et al.

Cancer Biology & Medicine|February 25, 2021

Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneityXuanming Chen, Cheng Shen, Zhe Wei, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Bioorganic Chemistry|August 14, 2022

SKLB-14b, a novel oral microtubule-destabilizing agent based on hydroxamic acid with potent anti-tumor and anti-multidrug resistance activitiesWanhua Zhang, Linyu Yang, Wenting Si, et al.

Cell Reports|January 18, 2026

Cancer-associated fibroblast-derived extracellular vesicles deliver ATP6V1C1 to promote lung adenocarcinoma metastasis via the ID1-IGFBP3 axisXuanming Chen, Jue Li, Cheng Shen, et al.

Cancer Biology & Medicine|February 25, 2021

Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneityXuanming Chen, Cheng Shen, Zhe Wei, et al.

Pageof 3